Stability and anti-tumor effect of oncolytic herpes simplex virus type 2

Oncolytic virotherapy is a new therapeutic strategy based on the inherent cytotoxicity of viruses and their ability to replicate and spread in tumors in a selective manner. We constructed a new type of oncolytic herpes simplex virus type 2 (oHSV-2, named OH2) to treat human cancers, but a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Jin, Jing, Wu, Zhen, Hu, Sheng, Hu, Han, Ning, Zhifeng, Li, Yanfei, Dong, Yuting, Zou, Jianwen, Mao, Zeyong, Shi, Xiaotai, Zheng, Huajun, Dong, Shuang, Liu, Fuxing, Fang, Zhizheng, Wu, Jiliang, Liu, Binlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973869/
https://www.ncbi.nlm.nih.gov/pubmed/29872496
http://dx.doi.org/10.18632/oncotarget.25122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973869/
https://www.ncbi.nlm.nih.gov/pubmed/29872496
http://dx.doi.org/10.18632/oncotarget.25122

Ejemplares similares